QbDVision Blog

  • All Posts
  • Blog
  • Events
  • News
  • QbDVision
  • Thought Leadership
All Posts
  • All Posts
  • Blog
  • Events
  • News
  • QbDVision
  • Thought Leadership
BlogNews

QbDVision Release: Leading the way in digital transformation for PLM

We’re excited to announce the next major iteration to QbDVision. Designed and validated top to bottom to bring you the latest tools to advance your pharmaceutical manufacturing activities.

Read more
BlogQbDVision

Putting It All Together: Process Risk Assessments (Part 7)

See how our platform builds risk in discrete layers that are designed to be updated and managed throughout the development lifecycle thus capturing the evolution of risk.

Read more
BlogQbDVision

Risk Management Plan Configuration: Process Risk Assessments (Part 6)

Explore how the structure of risk configuration in QbDVision produces easily understandable assessments to guide future work.

Read more
BlogQbDVision

The Non-Linear Factor: People – Process Risk Assessments (Part 5)

Last week, we saw how capturing uncertainty and detectability risk brings clarity and dimension while assessing risk when used appropriately. This week, we will look at the practical aspects of process risk assessments from a different lens: that of the people executing or using these tools.

Read more
BlogQbDVision

The Impostors: Uncertainty and Detectability Risk – Process Risk Assessments (Part 4)

Last week we explored how the concepts we’ve been discussing in our series line up with FMEA/FMECA methodologies. This week, we’ll explore the two impostors, uncertainty and detectability risk, a little bit further.

Read more
NewsQbDVision

CherryCircle Software Inc. Appoints Pasquale Sacco to Board of Directors

CherryCircle Software, Inc., maker of the QbDVision® software platform for knowledge and quality risk management in the life science industries, announced the appointment of Pasquale (Pat) Sacco to the Company’s Board of Directors.

Read more
BlogQbDVision

Focus on FMEA – Process Risk Assessments (Part 3)

Last week we discussed how to use the concepts of ISO 14971 to create a generalized framework for risk management that works across pharma and is compatible with (and leverages the best parts from) medical devices. This week, we’re going to take that one step further. We will explore how these concepts line up with FMEA/FMECA methodologies.

Read more
BlogQbDVision

ISO 14971 – Process Risk Assessments (Part 2)

Last week we defined a common structure and terms for process risk assessments. This was the first article in a series intended to rationalize and standardize the risk assessment discussion to communicate strategies that provide consistency, objectivity, and risk understanding.

Read more
BlogQbDVision

A Call for Structure – Process Risk Assessments (Part 1)

This blog post series is intended to rationalize and standardize the risk assessment discussion to communicate strategies that provide consistency, objectivity, and risk understanding. Over the next few weeks, we’ll be sharing strategies and approaches that explain how to manage these situations.

Read more

Harness your expertise

See how QbDVision can help you leverage your team’s know-how to accelerate drug development.